Portfolio Overview - The company's total annualized cash NOI is $405.128 million, with ISHC contributing $239.768 million (59.2%), OM contributing $81.172 million (20.0%), SHOP contributing $48.364 million (11.9%), Triple-Net Leased Properties contributing $29.900 million (7.4%), and Debt Security Investment contributing $5.924 million (1.5%) [10] - The portfolio consists of 294 properties, including 125 Integrated Senior Health Campuses (ISHC), 81 Outpatient Medical (OM) properties, 69 Senior Housing Operating Properties (SHOP), and 19 Triple-Net Leased Properties [10] Same-Store NOI Performance - Total Same-Store NOI increased by 15.1% from $82.067 million in Q1 2024 to $94.476 million in Q1 2025 [11] - ISHC Same-Store NOI increased by 19.8% from $49.086 million to $58.820 million [11] - SHOP Same-Store NOI increased significantly by 30.7% from $7.867 million to $10.286 million [11] - OM Same-Store NOI increased by 2.0% from $17.870 million to $18.227 million [11] - Triple-Net Leased Properties Same-Store NOI decreased slightly by 1.4% from $7.244 million to $7.143 million [11] Earnings Highlights - NAREIT FFO per share - diluted increased by 16.7% from $0.30 in Q1 2024 to $0.35 in Q1 2025 [12] - Normalized FFO per share - diluted increased by 26.7% from $0.30 in Q1 2024 to $0.38 in Q1 2025 [12] 2025 Guidance - The company projects a FY 2025 Total Portfolio Same-Store NOI Growth between 9.0% and 13.0% [48] - The company anticipates NAREIT FFO per diluted share between $1.49 and $1.55, and Normalized FFO per diluted share between $1.58 and $1.64 for FY 2025 [48]

Core Insights - American Healthcare REIT (AHR) reported revenue of $540.6 million for Q1 2025, marking an 8.2% year-over-year increase and exceeding the Zacks Consensus Estimate of $538.59 million by 0.37% [1] - The company achieved an EPS of $0.38, a significant improvement from -$0.04 a year ago, and surpassed the consensus EPS estimate of $0.37 by 2.70% [1] Revenue Breakdown - Resident fees and services generated $497.18 million, slightly above the average estimate of $495.43 million from two analysts [4] - Real estate revenue was reported at $43.43 million, which fell short of the average estimate of $44.43 million from two analysts [4] Stock Performance - Over the past month, shares of American Healthcare REIT have returned +12.3%, outperforming the Zacks S&P 500 composite's +11.3% change [3] - The stock currently holds a Zacks Rank 4 (Sell), indicating potential underperformance relative to the broader market in the near term [3]

American Healthcare REIT (AHR) came out with quarterly funds from operations (FFO) of $0.38 per share, beating the Zacks Consensus Estimate of $0.37 per share. This compares to FFO of $0.30 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an FFO surprise of 2.70%. A quarter ago, it was expected that this real estate investment trust would post FFO of $0.40 per share when it actually produced FFO of $0.40, delivering no surprise.Over the last four quar ...

Financial Performance - Reported GAAP net loss attributable to common stockholders of $(0.04) per diluted share for Q1 2025[5] - Net loss attributable to controlling interest for the three months ended March 31, 2025, was $6,804,000, compared to a net loss of $3,892,000 for the same period in 2024, indicating a deterioration in performance[33] - Net loss for Q1 2025 was $6,840,000, compared to a net loss of $3,004,000 in Q1 2024, representing an increase in loss of 128.5%[40] - The company reported a comprehensive loss of $6,664,000 for the three months ended March 31, 2025, compared to a comprehensive loss of $3,047,000 in the same period of 2024[33] Revenue and Income Growth - Total revenues for the three months ended March 31, 2025, increased to $540,603,000, up from $499,533,000 in the same period of 2024, representing an increase of approximately 8.2%[33] - Same-store revenue for Q1 2025 was $410,234,000, up from $377,787,000 in Q1 2024, an increase of 8.6%[53] - GAAP revenue for Q1 2025 was $540,603,000, compared to $499,533,000 in Q1 2024, reflecting a growth of 8.2%[53] - Net operating income (NOI) for Q1 2025 was $94,537,000, up from $82,177,000 in Q1 2024, reflecting a growth of 15.0%[46] - Achieved Same-Store Net Operating Income (NOI) growth of 15.1% for Q1 2025 compared to Q1 2024[5] - Cash NOI for Q1 2025 reached $101,026,000, compared to $90,046,000 in Q1 2024, marking a growth of 12.2%[46] - Adjusted EBITDA for Q1 2025 was $85,083,000, compared to $58,267,000 in Q1 2024, indicating an increase of 46.0%[38] Guidance and Projections - Increased total portfolio Same-Store NOI growth guidance for FY 2025 to a range of 9.0% to 13.0%[5] - Increased NFFO guidance for FY 2025 to a range of $1.58 to $1.64 per diluted share[5] - Full Year 2025 guidance for net income attributable to common stockholders is projected between $46.70 million and $56.10 million, up from the prior guidance of $40.59 million to $46.71 million[57] - NAREIT FFO attributable to common stockholders is expected to range from $236.40 million to $245.80 million, compared to the previous range of $233.08 million to $239.20 million[57] - Total Portfolio Same-Store NOI growth is forecasted between 9.0% and 13.0%, an increase from the prior range of 7.0% to 10.0%[57] - ISHC segment-level Same-Store NOI growth is anticipated to be between 12.0% and 16.0%, up from 10.0% to 12.0% previously[57] - SHOP segment-level Same-Store NOI growth is projected to be between 20.0% and 24.0%, compared to the prior range of 18.0% to 22.0%[57] - Normalized FFO attributable to common stockholders is expected to be between $250.60 million and $260.00 million, an increase from the previous range of $244.19 million to $250.31 million[57] - Net income per common share — diluted is projected to be between $0.29 and $0.35, compared to the prior range of $0.26 to $0.30[57] - NAREIT FFO per common share — diluted is expected to range from $1.49 to $1.55, consistent with the previous range of $1.49 to $1.53[57] - Normalized FFO per common share — diluted is projected to be between $1.58 and $1.64, compared to the prior range of $1.56 to $1.60[57] Expenses and Liabilities - General and administrative expenses increased to $13,155,000 in Q1 2025 from $11,828,000 in Q1 2024, a rise of 11.2%[40] - Interest expense decreased to $22,945,000 in Q1 2025 from $36,438,000 in Q1 2024, a reduction of 37.0%[40] - Business acquisition expenses were $1,837,000 in Q1 2025, down from $2,782,000 in Q1 2024, a decrease of 34.0%[40] - Total liabilities decreased to $2,159,343,000 as of March 31, 2025, from $2,183,895,000 as of December 31, 2024, a reduction of approximately 1.1%[28] Assets and Indebtedness - Total consolidated indebtedness was $1.67 billion as of March 31, 2025[11] - Cash and cash equivalents as of March 31, 2025, were $86,064,000, an increase from $76,702,000 as of December 31, 2024, showing a growth of approximately 12.8%[28] - Total assets decreased to $4,464,051,000 as of March 31, 2025, from $4,488,057,000 as of December 31, 2024, a decline of approximately 0.5%[28] Acquisitions and Developments - Developed a pipeline of over $300 million in new potential acquisitions as of May 8, 2025[8] - Started two new development projects with a total expected cost of approximately $60.0 million[9] - Completed a lease buyout in the ISHC segment for approximately $16.1 million during Q1 2025[10] Shareholder Information - Declared a cash distribution of $0.25 per share for the quarter ended March 31, 2025[15] - The weighted average number of diluted common shares outstanding increased to 157,428,446 for the three months ended March 31, 2025, compared to 104,295,142 in 2024, indicating a significant increase in share count[34] - Issued 1,577,113 shares of common stock through the ATM program for gross proceeds of approximately $47.7 million[12] Impairments - Impairment of real estate investment was reported at $21,706,000 in Q1 2025, with no such impairment recorded in Q1 2024[40]

Core Insights - American Healthcare REIT, Inc. reported strong performance in Q1 2025, with a Same-Store NOI growth of 15.1% compared to Q1 2024, driven by demand for long-term care and effective expense management [4][8][14] - The company has increased its full-year 2025 guidance for Same-Store NOI growth from a range of 7.0% to 10.0% to a revised range of 9.0% to 13.0% [8][14] - The company has a pipeline of over $300 million in potential acquisitions, indicating a proactive approach to external growth opportunities [6][8] Financial Performance - The company reported a GAAP net loss of $(6.8) million for Q1 2025, with a net loss per diluted share of $(0.04) [8][29] - Normalized Funds from Operations (NFFO) for Q1 2025 were reported at $0.38 per diluted share, reflecting a strong operational performance [8][32] - Total revenues for Q1 2025 increased to $540.6 million from $499.5 million in Q1 2024, primarily due to higher resident fees and services [29][40] Segment Performance - The ISHC segment achieved a Same-Store NOI growth of 19.8%, while the SHOP segment saw a growth of 30.7% in Q1 2025 compared to the same period in 2024 [5][8] - The outpatient medical segment reported a modest Same-Store NOI growth of 2.0%, while the triple-net leased properties experienced a decline of (1.4)% [5][8] Capital Markets and Balance Sheet - As of March 31, 2025, the company's total consolidated indebtedness was $1.67 billion, with a Net Debt-to-Annualized Adjusted EBITDA ratio of 4.5x [11][8] - The company raised approximately $47.7 million through the issuance of 1,577,113 shares of common stock during Q1 2025 [12][8] - The company has approximately $634.5 million in total liquidity, which includes cash, restricted cash, and undrawn capacity on its line of credit [11][8] Development and Transactional Activity - The company initiated two new development projects during Q1 2025, with a total expected cost of approximately $60.0 million [10][8] - A lease buyout in the ISHC segment was completed for approximately $16.1 million, and several non-core properties were sold for a total of approximately $39.0 million [9][8]

IRVINE, Calif., April 3, 2025 /PRNewswire/ -- American Healthcare REIT, Inc. (the "Company") (NYSE: AHR) announced today that it will issue its first quarter 2025 earnings release on Thursday, May 8, 2025, after the close of trading.A public conference call with a simultaneous webcast will be held on Friday, May 9, 2025, at 10:00 a.m. Pacific Time / 1:00 p.m. Eastern Time. During the conference call, company executives will review first quarter 2025 results, discuss recent events, and conduct a question-and ...

Core Insights - The article does not provide any specific company or industry insights, focusing instead on disclaimers and disclosures related to investment advice and positions held by the authors [1][2][3] Group 1 - The authors have no stock, option, or similar derivative positions in any of the companies mentioned and have no plans to initiate such positions within the next 72 hours [1] - The content is based on personal thoughts and research, emphasizing the need for readers to conduct their own due diligence before making investment decisions [2] - The article clarifies that past performance is not indicative of future results and that no specific investment recommendations are being made [3]

IRVINE, Calif., March 19, 2025 /PRNewswire/ -- American Healthcare REIT, Inc. (NYSE: AHR) announced today that its board of directors has declared a quarterly distribution of $0.25 per share for the quarter ending March 31, 2025. The distribution will be payable in cash on or about April 17, 2025, to all holders of record of its common stock as of the close of business on March 31, 2025.About American Healthcare REIT, Inc.American Healthcare REIT, Inc. (NYSE: AHR) is a real estate investment trust that acqu ...

Core Viewpoint - Chilton Capital Management's REIT Team focuses on investments in publicly traded real estate investment trusts (REITs) and related entities primarily in North America, emphasizing the advantages of liquidity, transparency, and total return characteristics of public REITs [1] Group 1: Team and Strategy - The REIT Team is led by co-portfolio managers Bruce Garrison and Matt Werner, with Garrison having over 40 years of experience in public REIT analysis [1] - The investment strategy combines real estate industry experience with traditional security analysis methods, including research and analytical depth [1] - The REIT Team manages Separately Managed Accounts (SMAs) for high net worth individuals and institutions, and serves as a sub-advisor for the West Loop Realty Fund [1] Group 2: Investment Focus - The REIT Team invests in a variety of property types, including apartments, regional malls, shopping centers, lodging, office, industrial, self-storage, data centers/cell towers, and healthcare-related facilities [1] - The focus on public securities allows for diversification across geography, sector, strategy, property, and tenant while maintaining portfolio liquidity [1]

Analyst’s Disclosure: I/we have a beneficial long position in the shares of RIET, HOMZ, IRET, ALL HOLDINGS IN THE IREIT+HOYA PORTFOLIOS either through stock ownership, options, or other derivatives. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article. Hoya Capital Research & Index Innovations (“Hoya Capital”) is an affiliate of Hoya Capi ...